1. Home
  2. NEE vs ABT Comparison

NEE vs ABT Comparison

Compare NEE & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextEra Energy Inc.

NEE

NextEra Energy Inc.

HOLD

Current Price

$94.91

Market Cap

190.4B

Sector

Utilities

ML Signal

HOLD

ABT

Abbott Laboratories

HOLD

Current Price

$92.90

Market Cap

183.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEE
ABT
Founded
1925
1888
Country
United States
United States
Employees
17400
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
190.4B
183.3B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
NEE
ABT
Price
$94.91
$92.90
Analyst Decision
Buy
Strong Buy
Analyst Count
12
20
Target Price
$94.75
$130.90
AVG Volume (30 Days)
7.9M
9.4M
Earning Date
04-23-2026
04-16-2026
Dividend Yield
2.62%
2.77%
EPS Growth
N/A
N/A
EPS
N/A
3.72
Revenue
N/A
$44,328,000,000.00
Revenue This Year
$15.92
$10.75
Revenue Next Year
$8.48
$8.10
P/E Ratio
$27.64
$24.61
Revenue Growth
N/A
5.67
52 Week Low
$63.88
$90.72
52 Week High
$97.63
$137.49

Technical Indicators

Market Signals
Indicator
NEE
ABT
Relative Strength Index (RSI) 59.24 30.66
Support Level $89.54 N/A
Resistance Level $95.52 $130.24
Average True Range (ATR) 1.99 2.39
MACD 0.27 -0.49
Stochastic Oscillator 66.30 17.12

Price Performance

Historical Comparison
NEE
ABT

About NEE NextEra Energy Inc.

NextEra Energy's regulated utility, Florida Power & Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with nearly 40 GW of generation capacity, including natural gas, nuclear, wind, and solar.

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Share on Social Networks: